Novel Colon Cancer Therapeutic Target Identified
The protein Importin-11 transports the cancer-causing protein βcatenin into the nucleus of colon cancer cells, where it can drive cell proliferation.
Related Articles
AI in Drug Design: From Hype to Real-World Results
By leveraging AI, drug developers are moving beyond incremental gains in efficiency and engaging previously undruggable targets.
StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer
Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, judging by how flat the company’s shares fared this…
Vaccine Innovations Beyond the Existing mRNA-Based Vaccines for COVID-19
Developers are finding new ways to leverage mRNA and other modalities to prevent or defeat various infectious diseases.
To Reverse Aging’s Clock, Adjust the Cell’s Machinery
Epigenetic, bioelectromic, synaptic, and senolytic interventions could rejuvenate cells and counter the effects of aging.
MilliporeSigma Opens Glitzy $286 Million Biosafety Testing Facility in Maryland
Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility would tackle major challenges including CAR-T…
Booster Therapeutics Secures $15M to Develop Proteasome Activators for Treating Complex Diseases
The company is developing molecules that boost the ubiquitin-independent protein degradation activity of 20S proteasomes in complex disorders.
Recursion’s Fast-Track Road to Therapeutics Using AI-Based Maps of Biology
The company reflects on their latest IND approval, the evolution of their end-to-end drug discovery platform, and what’s next for the field.
Bruker Unveils Spatial Strategy Post NanoString Acquisition
Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for the future.
Diverse Genomes Make Medicine More Equitable
Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our understanding of diseases.
AI-Powered Chatbots Unreliable for Patient Drug Information
While chatbots powered by artificial intelligence are likely to become a key source of information on the web, researchers have found that a considerable number…